🇺🇸 FDA
Patent

US 9655969

Inhalable medicament comprising tiotropium

granted A61KA61K31/439A61K31/46

Quick answer

US patent 9655969 (Inhalable medicament comprising tiotropium) held by Teva Branded Pharmaceutical Products R&D, Inc. expires Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Teva Branded Pharmaceutical Products R&D, Inc.
Grant date
Tue May 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 18 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/439, A61K31/46, A61K47/10, A61K47/12